Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvamibe vs High-intensity Rosuvastatin in ASCVD
NCT03494270Phase 4Completed
- Sponsor
- Yuhan
- Start
- Mar 2018
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ezetimibe + rosuvastatin in atherosclerotic cardiovascular disease (ASCVD), sponsored by Yuhan. Started Mar 2018; status: completed.
02
Drugs
ezetimibe + rosuvastatin
03
Conditions
atherosclerotic cardiovascular disease (ASCVD)
Beyond the preview
Go deeper on NCT03494270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03494270.